Percutaneous intervention

Citations 251-260 of 365 total displayed.

Cardiovascular medicine
Temporal evolution and functional outcome of no reflow: sustained and spontaneously reversible patterns following successful coronary recanalisation

L Galiuto, A Lombardo, A Maseri, L Santoro, I Porto, D Cianflone, A G Rebuzzi, and F Crea
Heart 2003; 89: 731-737. [Abstract] [Full text] [PDF] [Request Permissions]  

Interventional cardiology and surgery
High preprocedural non-HDL cholesterol is associated with enhanced oxidative stress and monocyte activation after coronary angioplasty: possible implications in restenosis

F Cipollone, M Fazia, A Iezzi, B Pini, F Costantini, D De Cesare, L Paloscia, G Materazzo, E D’Annunzio, T Bucciarelli, J Vecchiet, F Chiarelli, F Cuccurullo, and A Mezzetti
Heart 2003; 89: 773-779. [Abstract] [Full text] [PDF] [Request Permissions]  

Scientific letters
Same day discharge following elective percutaneous coronary intervention in patients with stable angina

A P Banning, O J M Ormerod, K Channon, C J McKenna, W Orr, B Boulton, Y Bashir, and J C Forfar
Heart 2003; 89: 665. [Extract] [Full text] [PDF] [Request Permissions]  

Scientific letters
The variation of plasma concentrations of a novel, adipocyte derived protein, adiponectin, in patients with acute myocardial infarction

S Kojima, T Funahashi, T Sakamoto, S Miyamoto, H Soejima, J Hokamaki, I Kajiwara, S Sugiyama, M Yoshimura, K Fujimoto, Y Miyao, H Suefuji, A Kitagawa, N Ouchi, S Kihara, Y Matsuzawa, and H Ogawa
Heart 2003; 89: 667. [Extract] [Full text] [PDF] [Request Permissions]  

Editorials
Who would I not give IIb/IIIa inhibitors to during percutaneous coronary intervention?

J M McLenachan
Heart 2003; 89: 477-478. [Extract] [Full text] [PDF] [Request Permissions]  

Interventional cardiology and surgery
Deaths associated with platelet glycoprotein IIb/IIIa inhibitor treatment

D L Brown
Heart 2003; 89: 535-537. [Abstract] [Full text] [PDF] [Request Permissions]  

Education in Heart
Indications for percutaneous and surgical revascularisation: how far does the evidence base guide us?

P M Schofield
Heart 2003; 89: 565-570. [Extract] [Full text] [PDF] [Request Permissions]  

Editorials
Coronary flow: clinical considerations

D V Cokkinos, A Manginas, and V Voudris
Heart 2003; 89: 361-363. [Extract] [Full text] [PDF] [Request Permissions]  

Education in Heart
Lipid lowering to delay the progression of coronary artery disease

Michael D Feher
Heart 2003; 89: 451-458. [Extract] [Full text] [PDF] [Request Permissions] [ Web-only References ]  

Editorials
Outcome following percutaneous coronary intervention: not, so far, in our genes

B Keavney
Heart 2003; 89: 247-248. [Extract] [Full text] [PDF] [Request Permissions]